StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)

Close on Nov 17, 2026Market cap $3.77MP/E –Yield –

Xenetic Biosciences cash

Cash and short-term investments held at the end of each period.

Xenetic Biosciences's cash was $6.47M at Jun 30, 2026. For fiscal 2025 it was $7.88M, up 27.9% from the year before. Over ten years it grew 50.5% a year on average. The highest annual figure on record is $18.24M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.88M+27.9%
FY2024Dec 31, 2024$6.17M-31.4%
FY2023Dec 31, 2023$8.98M-31.4%
FY2022Dec 31, 2022$13.10M-28.2%
FY2021Dec 31, 2021$18.24M+58.3%
FY2020Dec 31, 2020$11.53M+11.2%
FY2019Dec 31, 2019$10.37M+1524.8%
FY2018Dec 31, 2018$638.12K-88.6%
FY2017Dec 31, 2017$5.60M+36.1%
FY2016Dec 31, 2016$4.11M+3011.8%
FY2015Dec 31, 2015$132.23K-94.7%
FY2014Dec 31, 2014$2.51M-48.2%
FY2013Dec 31, 2013$4.84M-56.5%
FY2012Dec 31, 2012$11.14M-34.9%
FY2011Dec 31, 2011$17.12M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.47M+35.4%
Q1 FY2026Mar 31, 2026$7.35M+42.3%
Q4 FY2025Dec 31, 2025$7.88M+27.9%
Q3 FY2025Sep 30, 2025$4.12M-39.7%
Q2 FY2025Jun 30, 2025$4.78M-34.5%
Q1 FY2025Mar 31, 2025$5.16M-34.0%
Q4 FY2024Dec 31, 2024$6.17M-31.4%
Q3 FY2024Sep 30, 2024$6.84M-30.0%
Q2 FY2024Jun 30, 2024$7.30M-32.0%
Q1 FY2024Mar 31, 2024$7.82M-34.8%
Q4 FY2023Dec 31, 2023$8.98M-31.4%
Q3 FY2023Sep 30, 2023$9.78M-34.5%
Q2 FY2023Jun 30, 2023$10.73M-33.6%
Q1 FY2023Mar 31, 2023$11.99M-34.3%
Q4 FY2022Dec 31, 2022$13.10M-33.5%
Q2 FY2022Jun 30, 2022$14.93M+60.8%
Q1 FY2022Mar 31, 2022$16.16M+61.4%
Q4 FY2021Dec 31, 2021$18.24M+58.3%
Q3 FY2021Sep 30, 2021$19.70M+179.3%
Q2 FY2021Jun 30, 2021$9.28M+15.1%
Q1 FY2021Mar 31, 2021$10.01M+6.8%
Q4 FY2020Dec 31, 2020$11.53M+11.2%
Q3 FY2020Sep 30, 2020$7.05M-41.4%
Q2 FY2020Jun 30, 2020$8.07M+680.0%
Q1 FY2020Mar 31, 2020$9.37M+349.3%
Q4 FY2019Dec 31, 2019$10.37M+1524.8%
Q3 FY2019Sep 30, 2019$12.04M+617.4%
Q2 FY2019Jun 30, 2019$1.03M-68.9%
Q1 FY2019Mar 31, 2019$2.08M-47.0%
Q4 FY2018Dec 31, 2018$638.12K-88.6%
Q3 FY2018Sep 30, 2018$1.68M+120.6%
Q2 FY2018Jun 30, 2018$3.32M+38.6%
Q1 FY2018Mar 31, 2018$3.93M-9.0%
Q4 FY2017Dec 31, 2017$5.60M+36.1%
Q3 FY2017Sep 30, 2017$761.26K+259.3%
Q2 FY2017Jun 30, 2017$2.40M+896.1%
Q1 FY2017Mar 31, 2017$4.32M–
Q4 FY2016Dec 31, 2016$4.11M–
Q3 FY2016Sep 30, 2016$211.90K–
Q2 FY2016Jun 30, 2016$240.79K–

More Xenetic Biosciences figures

See a number that looks wrong?